Article Details
Retrieved on: 2024-09-26 20:21:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The U.S. biopharma company UCB announced this week that the FDA has extended its approval of BIMZELX (bimekizumab-bkzx) for the treatment of four ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here